STERIS Plc Company Insiders
STE Stock | USD 230.46 3.21 1.41% |
STERIS Plc employs about 17.8 K people. The company is managed by 25 executives with a total tenure of roughly 185 years, averaging almost 7.0 years of service per executive, having 711.48 employees per reported executive. Evaluation of STERIS Plc's management performance can provide insight into the firm performance.
Walter Rosebrough CEO CEO and President Director and Member of Compliance Committee |
Mohsen Sohi Chairman Independent Chairman of the Board |
STERIS Plc's latest congressional trading
Congressional trading in companies like STERIS plc, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in STERIS Plc by those in governmental positions are based on the same information available to the general public.
2025-07-03 | Representative April Delaney | Acquired Under $15K | Verify | ||
2025-03-28 | Representative Rob Bresnahan | Acquired Under $15K | Verify |
STERIS Plc Management Team Effectiveness
The company has Return on Asset of 0.0582 % which means that on every $100 spent on assets, it made $0.0582 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0946 %, implying that it generated $0.0946 on every 100 dollars invested. STERIS Plc's management efficiency ratios could be used to measure how well STERIS Plc manages its routine affairs as well as how well it operates its assets and liabilities.STERIS Plc Workforce Comparison
STERIS plc is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 115,513. STERIS Plc retains roughly 17,787 in number of employees claiming about 15% of equities under Health Care industry.
The company has Net Profit Margin of 0.11 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.2 %, which entails that for every 100 dollars of revenue, it generated $0.2 of operating income. STERIS Plc Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific STERIS Plc insiders, such as employees or executives, is commonly permitted as long as it does not rely on STERIS Plc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, STERIS Plc insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Julia Madsen over six months ago Disposition of 207 shares by Julia Madsen of STERIS Plc at 222.88 subject to Rule 16b-3 | ||
J Zangerle over six months ago Disposition of tradable shares by J Zangerle of STERIS Plc at 235.78 subject to Rule 16b-3 | ||
Cary Majors over six months ago Disposition of 1682 shares by Cary Majors of STERIS Plc at 217.32 subject to Rule 16b-3 | ||
Michael Tokich over six months ago Disposition of 771 shares by Michael Tokich of STERIS Plc at 228.37 subject to Rule 16b-3 | ||
Richard Steeves over six months ago Acquisition by Richard Steeves of 358 shares of STERIS Plc subject to Rule 16b-3 | ||
Julia Madsen over six months ago Disposition of 250 shares by Julia Madsen of STERIS Plc at 235.78 subject to Rule 16b-3 | ||
Michael Tokich over six months ago Disposition of 23332 shares by Michael Tokich of STERIS Plc at 114.22 subject to Rule 16b-3 | ||
Daniel Carestio over a year ago Disposition of 1063 shares by Daniel Carestio of STERIS Plc at 228.37 subject to Rule 16b-3 |
STERIS Plc Notable Stakeholders
A STERIS Plc stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as STERIS Plc often face trade-offs trying to please all of them. STERIS Plc's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting STERIS Plc's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Walter Rosebrough | CEO and President Director and Member of Compliance Committee | Profile | |
Mohsen Sohi | Independent Chairman of the Board | Profile | |
Daniel Carestio | Chief Operating Officer, Senior Vice President, Director | Profile | |
Karen Burton | CFO, Chief Accounting Officer, Vice President Controller | Profile | |
Renato Tamaro | Vice President and Corporate Treasurer | Profile | |
Michael Tokich | CFO, Principal Accounting Officer, Sr. VP and Treasurer | Profile | |
Richard Breeden | Independent Director | Profile | |
Michael Wood | Independent Director | Profile | |
Paul Martin | Independent Director | Profile | |
Jacqueline Kosecoff | Independent Director | Profile | |
Cynthia Feldmann | Independent Director | Profile | |
Nirav Shah | Independent Director | Profile | |
Richard Steeves | Independent Director | Profile | |
Loyal Wilson | Independent Director | Profile | |
Duncan Nichol | Independent Director | Profile | |
Christopher Holland | Independent Director | Profile | |
David Lewis | Independent Director | Profile | |
Mary Fraser | SVP Officer | Profile | |
J Zangerle | Senior Vice President General Counsel, Secretary | Profile | |
Julia Madsen | Senior Sciences | Profile | |
Andrew Xilas | Senior Dental | Profile | |
Julie Winter | Vice Communications | Profile | |
John Zangerle | Senior Vice President General Counsel, Secretary | Profile | |
Kenneth Kohler | Senior AST | Profile | |
Cary Majors | Vice President - North America Commercial Operations | Profile |
About STERIS Plc Management Performance
The success or failure of an entity such as STERIS plc often depends on how effective the management is. STERIS Plc management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of STERIS management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the STERIS management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company was founded in 1985 and is based in Dublin, Ireland. Steris Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 16000 people.
Please note, the presentation of STERIS Plc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, STERIS Plc's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of STERIS Plc's management manipulating its earnings.
STERIS Plc Workforce Analysis
Traditionally, organizations such as STERIS Plc use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare STERIS Plc within its industry.STERIS Plc Manpower Efficiency
Return on STERIS Plc Manpower
Revenue Per Employee | 306.9K | |
Revenue Per Executive | 218.4M | |
Net Income Per Employee | 34.6K | |
Net Income Per Executive | 24.6M | |
Working Capital Per Employee | 55K | |
Working Capital Per Executive | 39.1M |
Complementary Tools for STERIS Stock analysis
When running STERIS Plc's price analysis, check to measure STERIS Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STERIS Plc is operating at the current time. Most of STERIS Plc's value examination focuses on studying past and present price action to predict the probability of STERIS Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STERIS Plc's price. Additionally, you may evaluate how the addition of STERIS Plc to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |